Related Experiment Video

Updated: Aug 18, 2026

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

Wound healing after glaucoma surgery: how to manage it?

N J Collignon1

  • 1Service d'Ophtalmologie, CHU Sart-Tilman, 4000 Liège, Belgique.

Bulletin De La Societe Belge D'Ophtalmologie
|April 27, 2005
PubMed

Insights

Antimetabolites like 5-fluorouracil (5FU) and mitomycin-C (MMC) improve glaucoma surgery success but risk complications. Modifying their application can enhance safety and reduce side effects while preserving effectiveness.

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Pharmacology

Background:

  • Antimetabolites, including 5-fluorouracil (5FU) and mitomycin-C (MMC), are crucial in high-risk glaucoma surgery.
  • These agents significantly reduce the risk of surgical failure.
  • However, their use is associated with vision-threatening complications.

Purpose of the Study:

  • To explore modifications in the application of antimetabolites during and after glaucoma surgery.
  • To enhance patient safety and minimize vision-threatening complications.
  • To maintain the effectiveness of antimetabolites in high-risk glaucoma surgery.

Main Methods:

  • Review of existing literature on antimetabolite use in glaucoma surgery.
  • Analysis of application protocols and their impact on outcomes.
  • Comparative assessment of different application strategies.

Main Results:

  • Adjusting the timing and dosage of 5FU and MMC can mitigate risks.
  • Specific application modifications show potential for improved safety profiles.
  • Effectiveness in preventing surgical failure can be sustained with optimized protocols.

Conclusions:

  • Strategic changes in antimetabolite administration are key to improving safety in glaucoma surgery.
  • Optimized application can reduce severe complications while maintaining surgical efficacy.
  • Further research into refined antimetabolite protocols is warranted for high-risk patients.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...